Pramipexole Dihydrochloride
NDC 50228-128, Pramipexole Dihydrochloride, tablet, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-128
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203855
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-128 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE.5 mg/1
Pharmacologic classes
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-128-10 | 50228012810 | 1000 TABLET in 1 BOTTLE (50228-128-10) |
| 50228-128-90 | 50228012890 | 90 TABLET in 1 BOTTLE (50228-128-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/395fee34-43dc-4840-a6b8-70d5736f9c8b
Use it
Look up 50228-128 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-128 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-128. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.